Skip to content
God Of Sound – Lifestyle
Author:
OMEICOS Therapeutics GmbH
OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA
July 21, 2026